EUVIMEDEUVIMED entdecken
Crossref

Algometric assessment of sensitization and habituation as predictive markers for OnabotulinumtoxinA response in chronic migraine

Javier Gomez-Pilar iD, Fernando Vaquerizo-Villar iD, David García-Azorín iD, Álvaro Sierra-Mencía, Ángel Luis Guerrero-Peral iD, Roberto Hornero iD

Pain Medicine · 01.07.2026 · 27 (7) · 753-762

DOI: 10.1093/pm/pnag060 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pain Medicine, online erschienen am 26.04.2026. Verfasst von Javier Gomez-Pilar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Engineering Group, University of Valladolid, Valladolid, Spain. Hauptthemen laut MEDLINE: Migraine Disorders, Botulinum Toxins, Type A, Habituation, Psychophysiologic, Pain Measurement. Die Arbeit nennt 39 Literaturangaben. Gefördert von: MICIU/AEI/10.13039/501100011033, European Social Fund Plus, Consorcio Centro de Investigación Biomédica en Red.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic migraine is a debilitating disorder characterized by central sensitization and impaired habituation. Although OnabotulinumtoxinA (OnabotA) is an established preventive treatment, its precise mechanism of action and predictors of therapeutic response remain elusive. In this prospective cohort study, we integrated clinical parameters with algometric assessments, a recognized tool for evaluating peripheral sensitization, to develop machine learning-based predictive models to forecast migraine treatment response and effectiveness.

Methods

Seventy-six patients underwent comprehensive clinical evaluations and pressure pain threshold measurements. Key clinical and algometric variables were identified using a feature selection algorithm and incorporated into linear regression models for continuous outcomes (reductions in migraine days, headache days, symptomatic medication use, and triptan use) and an ordinal logistic regression model for categorical treatment response considering percentage of decrease in headache days [3 classes: low (<50%), moderate (50%-75%), and high (>75%) responders].

Results

The linear regression models yielded significant correlations, exemplified by a reduction in migraine days (ρ = 0.762, RMSE = 5.70) and symptomatic medication days (ρ = 0.503, RMSE = 7.84). Similarly, the ordinal logistic regression model achieved an overall accuracy of 56.6% to predict treatment effectiveness (κ = 0.334 for 3 classes), as well as 71.1%, 64.5%, and 77.6% accuracies to predict high, moderate, and low OnabotA response. Notably, incorporating algometric data significantly enhanced predictive performance compared to models based solely on clinical variables.

Conclusions

These findings support the potential of combined clinical and algometric evaluation as a practical biomarker for optimizing OnabotA therapy in chronic migraine, warranting further validation in larger, multicenter studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Migraine DisordersBotulinum Toxins, Type AHabituation, PsychophysiologicPain MeasurementPain ThresholdHumansFemaleMaleAdultProspective StudiesMiddle AgedTreatment OutcomeChronic DiseasePredictive Learning ModelsCohort Studies

Stichwörter der Autor:innen

OnabotAalgometrychronic migrainehabituationmachine learningsensitization

Substanzen

Botulinum Toxins, Type Aonabotulinum toxin A

Autor:innen und Institutionen

  • Biomedical Engineering Group, University of Valladolid, Valladolid, Spain.
  • Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Valladolid, Spain.
  • Valladolid Health Research Institute (IBioVALL), Valladolid, Spain.
  • Department of Neurology, Hospital Universitario Río Hortega, Valladolid, Spain.
  • Department of Medicine, University of Valladolid, Valladolid, Spain.
  • Headache Unit, Department of Neurology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.

ORCID-Profile: Javier Gomez-Pilar, Fernando Vaquerizo-Villar, David García-Azorín, Ángel Luis Guerrero-Peral, Roberto Hornero

Förderung

  • MICIU/AEI/10.13039/501100011033
  • European Social Fund Plus
  • Consorcio Centro de Investigación Biomédica en Red
  • Bioingeniería, Biomateriales
  • Nanomedicina
  • CIBER en Enfermedades Infecciosas
  • Instituto de Salud Carlos III
  • European Regional Development Fund. Sponsor

Zitieren

APA

Gomez-Pilar, J., Vaquerizo-Villar, F., García-Azorín, D., Sierra-Mencía, Á., Guerrero-Peral, Á. L., & Hornero, R. (2026). Algometric assessment of sensitization and habituation as predictive markers for OnabotulinumtoxinA response in chronic migraine. Pain Medicine, 27(7), 753-762. https://doi.org/10.1093/pm/pnag060

Vancouver

Gomez-Pilar J, Vaquerizo-Villar F, García-Azorín D, Sierra-Mencía Á, Guerrero-Peral ÁL, Hornero R. Algometric assessment of sensitization and habituation as predictive markers for OnabotulinumtoxinA response in chronic migraine. Pain Medicine. 2026;27(7):753-762. doi:10.1093/pm/pnag060

BibTeX
@article{GomezPilar2026,
  author = {Gomez-Pilar, Javier and Vaquerizo-Villar, Fernando and García-Azorín, David and Sierra-Mencía, Álvaro and Guerrero-Peral, Ángel Luis and Hornero, Roberto},
  title = {Algometric assessment of sensitization and habituation as predictive markers for OnabotulinumtoxinA response in chronic migraine},
  journal = {Pain Medicine},
  year = {2026},
  volume = {27},
  number = {7},
  pages = {753--762},
  doi = {10.1093/pm/pnag060}
}
Kostenlos starten →